Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis clinical trials

Explore recruiting metabolic dysfunction associated steatotic liver disease mash nonalcoholic steatohepatitis nash with fibrosis clinical trials.

Recruiting metabolic dysfunction associated steatotic liver disease mash nonalcoholic steatohepatitis nash with fibrosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

Spain, Poland, France, Italy, Bulgaria, Belgium +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis trials by city

Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis in Toronto Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis in Vancouver Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis in Montreal Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis in Calgary Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis in Edmonton Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis in Ottawa Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis in Winnipeg Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis in Quebec City Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis in Hamilton Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis in Kitchener Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis in London Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis in Halifax Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis in New York Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis in Los Angeles Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis in Chicago Metabolic Dysfunction Associated Steatotic Liver Disease Mash Nonalcoholic Steatohepatitis Nash With Fibrosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease